Health

FDA Approves Gene Therapy for Sickle Cell Disease

Updated 2026-07-08 15:10 UTC 1 source Positive

The U.S. Food & Drug Administration has approved a new gene therapy treatment for children aged 2 or older with sickle cell disease.

Coverage timeline — 1 article
The Hill
A new treatment for children aged 2 or older with sickle cell disease has been approved by the U.S. Food & Drug Administration.
2026-07-08 14:31 UTC
Share: Twitter / X LinkedIn